Andrea F. Wainer - 28 Feb 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2025, 20:05:21 UTC
Prior SEC filing
27 Feb 2025
Next SEC filing
14 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Andrea F. Wainer filed Form 4 for ABBOTT LABORATORIES (ABT) on 04 Mar 2025.

Key facts

  • This page summarizes Andrea F. Wainer's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Mar 2025, 20:05.

Change

  • Previous filing in this sequence was filed on 27 Feb 2025.
  • Current net transaction value: -$1,124,741.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value
$993,617
Shares
-7,313
Change %
-8.8%
Price
$135.87
Shares after
75,330
Date
28 Feb 2025
Ownership
Direct
ABT transaction

Common shares without par value

Sale

Transaction value
$131,123
Shares
-949
Change %
-1.3%
Price
$138.17
Shares after
74,381
Date
03 Mar 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Andrea F. Wainer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .